KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Tax Provisions (2009 - 2026)

Johnson & Johnson recorded quarterly Tax Provisions of $755.0 million in Q1 2026, up 603.33% quarter-over-quarter from -$150.0 million in Q4 2025, and down 71.31% year-over-year from $2.6 billion in Q1 2025.

Johnson & Johnson's Tax Provisions history runs 18 years deep, the most recent figure standing at $755.0 million for Q1 2026.

  • In Q1 2026, Tax Provisions fell 71.31% year-over-year to $755.0 million; the TTM figure through Mar 2026 stood at $3.9 billion (down 18.65% YoY), while the FY2025 annual figure was $5.8 billion, up 120.41% from the prior year.
  • Tax Provisions came in at $755.0 million for Q1 2026 at Johnson & Johnson, up from -$150.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.6 billion in Q1 2025 to a low of -$796.0 million in Q2 2023.
  • A 5-year average of $863.6 million and a median of $862.0 million in 2022 frame the typical range for Tax Provisions.
  • Across the five-year window, Tax Provisions slumped 211.64% in 2023 and soared 473.42% in 2025, its largest moves.
  • Johnson & Johnson's Tax Provisions stood at $862.0 million in 2022, then dropped by 19.49% to $694.0 million in 2023, then sank by 34.29% to $456.0 million in 2024, then plunged by 132.89% to -$150.0 million in 2025, then jumped by 603.33% to $755.0 million in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods registered $755.0 million, -$150.0 million, and $2.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 1.45 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 755.00 Mn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 342.00 Mn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 709.00 Mn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 265.00 Mn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 559.00 Mn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 461.00 Mn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 561.00 Mn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 755.00 Mn
Dec 28, 2025 -150.00 Mn
Sep 28, 2025 2.34 Bn
Jun 29, 2025 954.00 Mn
Mar 30, 2025 2.63 Bn
Dec 29, 2024 456.00 Mn
Sep 29, 2024 644.00 Mn
Jun 30, 2024 1.06 Bn
Mar 31, 2024 459.00 Mn
Dec 31, 2023 694.00 Mn
Oct 1, 2023 908.00 Mn
Jul 2, 2023 930.00 Mn
Apr 2, 2023 -796.00 Mn
Jan 1, 2023 1.19 Bn
Oct 2, 2022 862.00 Mn
Jul 3, 2022 1.03 Bn
Apr 3, 2022 713.00 Mn
Oct 3, 2021 182.00 Mn
Jul 4, 2021 384.00 Mn
Apr 4, 2021 1.23 Bn
Jan 3, 2021 -91.00 Mn
Sep 27, 2020 847.00 Mn
Jun 28, 2020 314.00 Mn
Mar 29, 2020 713.00 Mn
Dec 29, 2019 208.00 Mn
Sep 29, 2019 -106.00 Mn
Jun 30, 2019 1.43 Bn
Mar 31, 2019 673.00 Mn
Dec 30, 2018 80.00 Mn
Sep 30, 2018 489.00 Mn
Jul 1, 2018 1.02 Bn
Apr 1, 2018 1.11 Bn
Dec 31, 2017 13.27 Bn
Oct 1, 2017 1.03 Bn
Jul 2, 2017 921.00 Mn
Apr 2, 2017 1.15 Bn
Jan 1, 2017 19.00 Mn
Oct 2, 2016 1.01 Bn
Jul 3, 2016 907.00 Mn
Apr 3, 2016 837.00 Mn
Sep 27, 2015 764.00 Mn
Jun 28, 2015 1.23 Bn
Mar 29, 2015 1.26 Bn
Dec 28, 2014 182.00 Mn
Sep 28, 2014 2.06 Bn
Jun 29, 2014 1.30 Bn
Mar 30, 2014 697.00 Mn
Dec 29, 2013 -769.00 Mn
Sep 29, 2013 685.00 Mn
Jun 30, 2013 960.00 Mn
Mar 31, 2013 764.00 Mn
Dec 30, 2012 533.00 Mn
Sep 30, 2012 966.00 Mn
Jul 1, 2012 627.00 Mn
Apr 1, 2012 1.14 Bn
Jan 1, 2012 -638.00 Mn
Oct 2, 2011 909.00 Mn
Jul 3, 2011 646.00 Mn
Apr 3, 2011 1.03 Bn
Oct 3, 2010 802.00 Mn
Jul 4, 2010 771.00 Mn
Apr 4, 2010 1.75 Bn
Jan 3, 2010 398.00 Mn
Sep 27, 2009 900.00 Mn
Jun 28, 2009 1.06 Bn
Mar 29, 2009 1.14 Bn